Iambic Therapeutics
Iambic Therapeutics is a biotech company that uses AI to design differentiated drug candidates, with a clinical pipeline targeting HER2, KIF18A, and CDK2/4.

Notable is a healthcare automation platform that deploys AI agents across patient access, revenue cycle, care operations, and contact center work. It is built for health systems, health plans, and provider organizations that want to reduce administrative load without adding staff.
Notable is a healthcare automation platform that deploys AI agents across patient access, revenue cycle, care operations, and contact center work, aimed at health systems and health plans that need to handle growing patient volume without proportional staffing increases.
Notable frames its offering as an AI agent workforce rather than a single-purpose tool. The platform assigns agents to distinct roles, including revenue cycle, clinical documentation, referrals coordination, front desk, and authorizations. The intent is to let one organization spread automation across departments instead of buying separate point solutions for each task. That breadth matters in healthcare, where administrative work often crosses departmental lines and handoffs between teams create delays.
Flow Compass organizes automation around a four-step cycle: plan, do, monitor, and improve. The design puts healthcare operators in charge of the AI workforce, letting them redesign work, govern automation, and refine outcomes over time. Flow Builder supports the creation and launch of custom automations, while Sidekick lets users describe workflows in natural language. Integrations and AI skills extend those workflows at scale. Together these components position the platform as a UI automation tool with a management layer on top, so teams can adjust processes as conditions change rather than treating automation as a fixed installation.
A notable area of focus is HCC Chart Review, which supports risk adjustment and documentation accuracy for Medicare Advantage and ACA populations. The tool surfaces suspected conditions and embeds supporting evidence from the patient chart directly into the provider's EHR workflow, so care teams do not have to dig through cluttered problem lists. A suspecting capability also flags new conditions for provider review. This approach aims to expand the capacity of existing staff rather than requiring dedicated chart-review hires.
Security Health Plan and Marshfield Clinic Health System deployed HCC Chart Review first at small clinics, then expanded enterprise-wide in under three months from kickoff. The organizations reported more than 2,800 additional conditions documented annually across more than 15,000 members reviewed, translating to an additional $5.4M annually. The suspecting tool identified 440 conditions addressed and submitted in the first eight months of 2024, tied to more than $1.7M in additional revenue. Overall impact reached a $467 per member per year improvement across the Medicare Advantage population, and the full Marshfield organization captures roughly 7,000 additional conditions annually. Security later extended the tool to its ACA population, deploying in one month. These figures come from a single customer account and reflect that organization's circumstances.
Security also used the platform to reach prospective Medicare Advantage members during pre-appointment check-in at Marshfield, reporting a 13.4% patient engagement rate in the first week. Automated care gap closure flows were in deployment at the time of the account. This illustrates how the same platform can support outreach and enrollment alongside back-office documentation.
The platform emphasizes enterprise-grade security, and Notable publishes a dedicated security center alongside compliance credentials. For healthcare organizations handling protected health information, that posture is a baseline requirement rather than a differentiator.
Notable suits organizations that want a single platform spanning several administrative functions and are prepared to invest in EHR integration and change management. The published results are encouraging but tied to specific deployments, so prospective buyers should weigh their own workflow complexity and staffing model against the documented outcomes.
Subscription pricing is not listed.
Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 16, 2026 →
Iambic Therapeutics is a biotech company that uses AI to design differentiated drug candidates, with a clinical pipeline targeting HER2, KIF18A, and CDK2/4.
Microsoft for Healthcare brings Dragon Copilot, Dragon Medical One, and PowerMic Mobile to clinicians, combining speech recognition and an AI clinical assistant to streamline documentation and clinical tasks.
IQVIA provides life sciences organizations with data, analytics, and technology to accelerate innovation, improve patient outcomes, and bring treatments to market faster.
Tempus is a precision medicine platform that combines genomic testing and clinical data with AI to support oncology, cardiology, neurology, and psychiatry care and research.